For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessive pattern. The disease is named after the Danish neurologist Knud Krabbe (1885-1965).
This report elaborates the market size, market characteristics, and market growth of the Cell Leukodystrophy (Krabbe Disease) industry, and breaks down according to the type, application, and consumption area of Cell Leukodystrophy (Krabbe Disease). The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Cell Leukodystrophy (Krabbe Disease) in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Cell Leukodystrophy (Krabbe Disease) market covered in Chapter 13:
Shire
Novartis AG
Sanofi SA
Abbott Laboratories
UCB Pharmaceuticals
Teva Pharmaceutical Industries Ltd
??Johnson?Johnson
Pfizer
GlaxoSmithKline
In Chapter 6, on the basis of types, the Cell Leukodystrophy (Krabbe Disease) market from 2015 to 2025 is primarily split into:
3-6 months
15 months - 10 years old
In Chapter 7, on the basis of applications, the Cell Leukodystrophy (Krabbe Disease) market from 2015 to 2025 covers:
Hospitals
Clinics
Research centers
Others.
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025